Bladder spatial-dose descriptors correlate with acute urinary toxicity after radiation therapy for prostate cancer. Issue 12 (December 2016)

• Record Type: Journal Article
• Authors: Improta, I.; Palorini, F.; Cozzarini, C.; Rancati, T.; Avuzzi, B.; Franco, P.; Degli Esposti, C.; Del Mastro, E.; Girelli, G.; Iotti, C.; Vavassori, V.; Valdagni, R.; Fiorino, C.
• Is Part Of: Physica medica. Volume 32:Issue 12(2016)
• Page Start: 1681
• Page End: 1689
• Publication Date: 2016-12
• Subjects: Prostate radiotherapy -- Acute urinary toxicity -- Dose-surface maps -- Bladder spatial-dose descriptors; Medical physics -- Periodicals; Biophysics -- Periodicals; Biophysics -- Periodicals; Imagerie médicale -- Périodiques; Radiothérapie -- Périodiques; Rayons X -- Sécurité -- Mesures -- Périodiques; Physique -- Périodiques; Médecine -- Périodiques; 610.153
• DOI: 10.1016/j.ejmp.2016.08.013
• Languages: English
• ISSNs: 1120-1797

Abstract

Highlights: Application of a pixel-wise method for analysis of bladder dose surface maps (DSMs). Extraction of spatial-dose descriptors associated with the risk of urinary toxicity. An impact of trigone dose on urinary toxicity is found in the whole/HYPO populations. A cranial extension of the 75 Gy isodose emerges for conventionally treated patients. DSM descriptors improve the performance of models for predicting urinary toxicity. Abstract: Purpose: To assess bladder spatial-dose parameters predicting acute urinary toxicity after radiotherapy for prostate cancer (PCa) through a pixel-wise method for analysis of bladder dose-surface maps (DSMs). Materials & methods: The final cohort of a multi-institutional study, consisting of 539 patients with PCa treated with conventionally (CONV:1.8–2 Gy/fr) or moderately hypo-fractionated radiotherapy (HYPO:2.2–2.7 Gy/fr) was considered. Urinary toxicity was evaluated through the International Prostate Symptoms Score (IPSS) administered before and after radiotherapy. IPSS increases ⩾10 and 15 points at the end of radiotherapy (ΔIPSS ⩾ 10 and ΔIPSS ⩾ 15) were chosen as endpoints. Average DSMs (corrected into 2 Gy-equivalent doses) of patients with/without toxicity were compared through a pixel-wise method. This allowed the extraction of selected spatial descriptors discriminating between patients with/without toxicity. Previously logistic models based on dose-surface histograms (DSH) were considered and replaced with DSM descriptors. Discrimination power, calibration and log-likelihood were considered to evaluate the impact of the inclusion of spatial descriptors. Results: Data of 375/539 patients were available. ΔIPSS ⩾ 10 was recorded in 76/375 (20%) patients, while 30/375 (8%) experienced ΔIPSS ⩾ 15. The posterior dose at 12 mm from the bladder base (roughly corresponding to the trigone region) resulted significantly associated to toxicity in the whole/HYPO populations. The cranial extension of the 75 Gy isodose along the bladder central axis was the best DSM-based predictor in CONV patients. Multi-variable models including DSM descriptors showed better discrimination (AUC = 0.66–0.77) when compared to DSH-based models (AUC = 0.58–0.71) and higher log-likelihoods. Conclusion: DSMs are correlated with the risk of acute GU toxicity. The incorporation of spatial descriptors improves discrimination and log-likelihood of multi-variable models including dosimetric and clinical parameters.